Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA adjuvant treatment after liver transplantation (TailStudy)
ChiCTR-TRC-11001308Phase 4Completed
- Sponsor
- Guangdong Provincial Department of Science and Technology
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tauroursodeoxycholic acid in chronic liver disease (CLD), Cirrhosis and liver cancer (2 arms), sponsored by Guangdong Provincial Department of Science and Technology. Primary endpoints: Biliary complications, Acute rejection episodes and 3 more. Started May 2011; status: completed.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
chronic liver disease (CLD)Cirrhosisliver cancer
Beyond the preview
Go deeper on ChiCTR-TRC-11001308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001308.